Biodel Financial Statements
Biodel Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | September |
This data is provided as per license from EDGAR Online
Biodel Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (24.3) | (7.5) | (3.4) |
| Total Net Income ($ mil.) | (22.5) | (8.1) | (3.4) |
| Diluted EPS (Net Income) | (1.76) | (1.62) | (0.64) |
Biodel Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (10.6) | (11.7) | (9.3) |
| Total Net Income ($ mil.) | (9.6) | (11.0) | (8.4) |
| Diluted EPS (Net Income) | (0.42) | (0.55) | (0.33) |
Biodel Stock Quote & Chart
09/05/08 15:00:04 EST •
NASDAQ •
17.04
•
 -0.9600
•
-5.3333 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Biodel Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.69 | 1.54 |
| Price/Earnings Ratio | -- | 15.22 | 15.51 |
| Price/Book Ratio | 4.09 | 2.94 | 1.48 |
| Price/Cash Flow Ratio | -- | 12.49 | 9.68 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Biodel Financial Ratios
Biodel Competitive Intelligence
| Eli Lilly | Novo Nordisk | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,633.5 | 8,261.6 | 43,019.0 |
| Employees | 40,600 | 26,000 | 99,495 |
| Market Cap ($ mil.) | 53,902.8 | -- | -- |
Competitive Landscape
